XML 68 R53.htm IDEA: XBRL DOCUMENT v3.22.1
GOODWILL AND INTANGIBLE ASSETS - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2020
Intangible Assets [Line Items]      
Aggregate amortization expense related to finite-lived intangible assets $ 445 $ 395  
In-process research and development impairment 2,700 $ 0  
In Process Research And Development Trodelvy For HR+/HER2-      
Intangible Assets [Line Items]      
Indefinite-lived intangible assets, fair value 6,100    
Fair Value, Nonrecurring | In Process Research And Development Trodelvy For HR+/HER2-      
Intangible Assets [Line Items]      
In-process research and development impairment $ 2,700    
Immunomedics | In Process Research And Development Trodelvy For HR+/HER2-      
Intangible Assets [Line Items]      
Indefinite-lived intangible assets     $ 8,800
Immunomedics | In Process Research And Development Trodelvy For HR+/HER2- | Discount Rate      
Intangible Assets [Line Items]      
Discount rate, measurement input 6.75%